Published in
Springer Verlag, European Journal of Nuclear Medicine and Molecular Imaging, 11(37), p. 2027-2036
DOI: 10.1007/s00259-010-1524-z
Links
- ORCID
- Springer Verlag
- [boris.unibe.ch]
- [boris.unibe.ch] | PDF
- [doc.rero.ch] | PDF
- [www.researchgate.net] | PDF
Tools
PET/CT-guided biopsies of metabolically active bone lesions: applications and clinical impact
Journal article published in 2010 by
Bernd Klaeser,
Jakub Wiskirchen,
Jan Wartenberg,
Thilo Weitzel,
Ralph A. Schmid 
,
Michel D. Mueller,
Thomas Krause
,
Michel D. Mueller,
Thomas Krause
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
In a minority of cases a definite diagnosis and stage grouping in cancer patients is not possible based on the imaging information of PET/CT. We report our experience with percutaneous PET/CT-guided bone biopsies to histologically verify the aetiology of hypermetabolic bone lesions.